Munich, September 2017: Quantum Capital Partners GmbH, an international investment company based in Munich, has sold all shares in Weyhe-based mdexx GmbH to the Zhuzhou Lince Group Co. Limited (Lince). Both parties agreed to keep the purchase price confidential.
After a successful reorientation and a sustained return of mdexx to profitability, the ideal strategic partner for the future development of mdexx was chosen with Lince. For Quantum, the sale of mdexx marks a successful exit for their first fund which was incepted in 2014.
Quantum was advised in this transaction by TRACC Legal under the leadership of Dr. Thomas Lotz. Rödl & Partner, led by Klaus Martin Haussmann, oversaw this transaction on behalf of the buyer Lince.
About the mdexx Group
The mdexx Group develops and produces transformers, power supplies, throttles and filters, as well as axial and radial ventilators, especially for the rail sector but also for the medical technology sector. A workforce of around 500 employees is located at the sites in Weyhe (Germany), Trutnov (Czech Republic) and Tianjin (China).
About Quantum Capital Partners
Quantum Capital Partners is focused on companies with considerable development potential, with the goal to achieve a sustainable growth and ensure a profitable future for these. The first fund was incepted in 2014. The mdexx Group was part of its portfolio since 2016. Quantum manages a portfolio of European companies with aggregate sales of more than EUR 1bn.
About the Lince Group
Lince was established in 1979 and is headquartered in Zhuzhou, Hunan Province, China. Lince is a supplier to the rail sector and is manufacturing products such as brake systems and ventilators. With a workforce of around 4,000 employees the group generated a total turnover of approx. 450 million euros in 2016. By acquiring the mdexx Group, Lince has gained entry into the European market. At the same time, the mdexx Group is obtaining a stronger position in the Chinese market through this strategic investor.
Tilman Richter, Director
Tel.: +49 89 45 213 29 12